生物对角化学:针对向蛋白质降解的新兴策略
Pijun Zhou1, Junda Li1, Jinyi Xu1
1Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China.
Chemistry (Weinheim an der Bergstrasse, Germany)
|December 12, 2025
概括
生物对等化学增强了向蛋白降解 (TPD) 技术,通过解决药物耐药性和非向毒性等挑战. 这种方法改善了传统的TPD药物,扩大了它们的治疗潜力.
科学领域:
- 生物化学 生物化学
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
背景情况:
- 向性蛋白质降解 (TPD) 提供了一种针对药物耐药性和不可抗药性点的新疗法策略.
- 传统的TPD药物面临的局限性包括药理动力学不佳 (违反利宾斯基的五项规则),非标毒性和效应.
研究的目的:
- 审查最近在将生物对角化学与TPD技术整合方面的进展.
- 要突出生物对等化学如何解决当前TPD剂的局限性.
主要方法:
- 在TPD中使用生物对等化学的研究的文献综述.
- 分析自组装TPD剂和使用生物对等反应的前药物策略.
主要成果:
- 生物直角化学为TPD剂药效性挑战提供了解决方案.
- 开发自组装的TPD代理和前期药物提高了特异性,降低了毒性.
- 通过合理设计生物直角TPD系统来克服效应.
结论:
- 将生物对角化学与TPD技术相结合是克服现有局限性的有希望的策略.
- 这种方法增强了TPD药物的治疗潜力,用于以前无法治疗的目标.
- 未来的研究方向侧重于进一步优化生物直角TPD系统的临床应用.
相关概念视频
Regulated Protein Degradation
8.7K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.7K
Regulated Protein Degradation
3.0K
3.0K
The Proteasome
10.0K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.0K
The Proteasome
1.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K
Protein Networks
4.5K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.5K
Targets for Drug Action: Overview
9.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.9K


